With the support of Laurea University of Applied Sciences (HQ in Vantaa, Finland) and the Municipality of the Lublin City, as a coordinator of the Lublin Medicine Cluster, SDS Optic – SME from Lublin, Poland had an opportunity to present its inPROBE HER2+ Breast Cancer Diagnostics technology on November 15th 2019 at Women’s Hospital, part of Helsinki University Hospital in Finland.
HUS is the largest hospital in Finland, very opinion leading center and a scientific center for new medical technologies coming into Finland. The Women’s Hospital and its Radiology unit performs in average 10 breast biopsies a day and the Surgical Oncology unit performs around 1500 surgeries a year which makes the hospital the largest cancer diagnostics and surgical oncology center in Finland.
SDS Optic has benefited largely from this “ProVaHealth – Product Validation in Health” project. It has been crucial to company’s further clinical development having a chance to discuss inPROBE technology specifics and potential future medical applications with PhD, MD Katja Hukkinen – HUS Radiology Key Expert in the clinical technology – Mateusz Sagan, Company’s Chief Business Officer.
The meeting was a part of the international “ProVaHealth – Product Validation in Health” project co-financed by the European Union through the European Regional Development Fund under Interreg Baltic Sea Region Programme 2014-2020.
ProVaHealth facilitates access to health infrastructures for startups and SMEs aiming for commercialization with excellent client validation opportunities, hands-on feedback and input for product development.
More information about the project can be found at: scanbalt.org/livinglabs/ and http://medycyna.lublin.eu/provahealth/.
